Multiple sclerosis treatment and infectious issues: update 2013

Por Winkelmann, A, Loebermann, M, Reisinger, E C, Zettl, U K
Publicado em 2014

CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflamma...

Por Dudesek, A, Rimmele, F, Tesar, S, Kolbaske, S, Rommer, P S, Benecke, R, Zettl, U K
Publicado em 2014

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

Por Rommer, P S, Zettl, U K, Kieseier, B, Hartung, H-P, Menge, T, Frohman, E, Greenberg, B M, Hemmer, B, Stüve, O
Publicado em 2014

Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients

Por Rommer, P. S., Kamin, F., Petzold, A., Tumani, H., Abu-Mugheisib, M., Koehler, W., Hoffmann, F., Winkelmann, A., Benecke, R., Zettl, U. K.
Publicado no Mol Diagn Ther (2014)

Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study

Por Faiss, J H, Dähne, D, Baum, K, Deppe, R, Hoffmann, F, Köhler, W, Kunkel, A, Lux, A, Matzke, M, Penner, I K, Sailer, M, Zettl, U K
Publicado em 2014

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS

Por Schrewe, L., Lill, C. M., Liu, T., Salmen, A., Gerdes, L. A., Guillot-Noel, L., Akkad, D. A., Blaschke, P., Graetz, C., Hoffjan, S., Kroner, A., Demir, S., Böhme, A., Rieckmann, P., ElAli, A., Hagemann, N., Hermann, D. M., Cournu-Rebeix, I., Zipp, F., Kümpfel, T., Buttmann, M., Zettl, U. K., Fontaine, B., Bertram, L., Gold, R., Chan, A.
Publicado no J Neuroinflammation (2015)